CIN- L67120MH1995PLC084899

Login

Login

Generate password

Forgot Customer Code

Would you like to create a personalised login id for logging in to Emkay Website ?

Change Personalised Login ID

Alivus Life Sciences Ltd.

NSE : ALIVUSEQ BSE : 543322 ISIN CODE : INE03Q201024Industry : Pharmaceuticals

News

  • Alivus Life Sciences - Disclosure Under Regulation 30 Of SEBI (LODR) Regulations, 2015 21 Mar 2026 | 12:46 | Dion Global

    Kindly refer attachment.more...

  • Alivus Life Sciences - Analysts/Institutional Investor Meet/Con. Call Updates 12 Mar 2026 | 16:58 | Dion Global

    Alivus Life Sciences Limited has informed the Exchange about Schedule of Analyst / Institutional Investor meeting.more...

  • Alivus Life Sciences - Announcement under Regulation 30 (LODR)-Analyst / Investor Meet - Intimation 12 Mar 2026 | 16:56 | Dion Global

    Disclosure under Regulation 30 of the SEBI (Listing Obligation and Disclosure Requirements) Regulations 2015 - Intimation of Investors/Analyst Meetingmore...

  • Alivus Life Sciences - Analysts/Institutional Investor Meet/Con. Call Updates 06 Mar 2026 | 16:56 | Dion Global

    Alivus Life Sciences Limited has informed the Exchange about Schedule of Analyst/Institutional Investor meetingsmore...

  • Alivus Life Sciences - Announcement under Regulation 30 (LODR)-Analyst / Investor Meet - Intimation 06 Mar 2026 | 16:54 | Dion Global

    Disclosure under Regulation 30 of SEBI (Listing Obligation and Disclosure Requirements) Regulations 2015 - Intimation of Investors/Analyst Meetingmore...

  • Alivus Life Sciences - Updates 25 Feb 2026 | 19:52 | Dion Global

    Alivus Life Sciences Limited has informed the Exchange regarding Disclosure under Regulation 30 of SEBI LODR .more...

  • Alivus Life Sciences - Disclosure Under Regulation 30 Of The Securities And Exchange Board Of India (Listing Obligations And 25 Feb 2026 | 19:48 | Dion Global

    Kindly refer attachment.more...

  • Alivus Life Sciences - General Updates 16 Feb 2026 | 11:44 | Dion Global

    Alivus Life Sciences Limited has informed the Exchange about General Updatesmore...

  • Alivus Life Sciences - Announcement Under Regulation 30 - Updates 16 Feb 2026 | 11:44 | Dion Global

    Kindly refer the enclosed attachment.more...

  • Alivus Life Sciences - Announcement under Regulation 30 (LODR)-Analyst / Investor Meet - Intimation 02 Feb 2026 | 17:27 | Dion Global

    Kindly refer enclosed attachment.more...

  • Alivus Life Sciences - Analysts/Institutional Investor Meet/Con. Call Updates 02 Feb 2026 | 17:23 | Dion Global

    Alivus Life Sciences Limited has informed the Exchange about Schedule of meetmore...

  • Alivus Life Sciences - Analysts/Institutional Investor Meet/Con. Call Updates 30 Jan 2026 | 18:45 | Dion Global

    Alivus Life Sciences Limited has informed the Exchange about Transcript of Earnings Callmore...

  • Alivus Life Sciences - Announcement under Regulation 30 (LODR)-Earnings Call Transcript 30 Jan 2026 | 18:43 | Dion Global

    Please find enclosed herewith transcript of Earnings Call held on 22nd January 2026 which is also made available on the website of the Company.more...

  • Alivus Life Sciences - General Updates 30 Jan 2026 | 17:41 | Dion Global

    Alivus Life Sciences Limited has informed the Exchange about General Updatesmore...

  • Alivus Life Sciences - Analysts/Institutional Investor Meet/Con. Call Updates 28 Jan 2026 | 14:48 | Dion Global

    Alivus Life Sciences Limited has informed the Exchange about Schedule of Analyst/Institutional Investor meetings.more...

  • Alivus Life Sciences - Announcement under Regulation 30 (LODR)-Analyst / Investor Meet - Intimation 28 Jan 2026 | 14:44 | Dion Global

    Disclosure under Regulation 30 of SEBI (Listing Obligation and Disclosure Requirements) Regulations 2015 - Intimation of Investors/Analyst Meetingmore...

  • Alivus Life Sciences - Analysts/Institutional Investor Meet/Con. Call Updates 22 Jan 2026 | 20:04 | Dion Global

    Alivus Life Sciences Limited has informed the Exchange about Link of Recording of Earnings Callmore...

  • Alivus Life Sciences - Announcement under Regulation 30 (LODR)-Analyst / Investor Meet - Outcome 22 Jan 2026 | 20:00 | Dion Global

    Pursuant to the Regulation 30 and 46 read with Part A of Schedule III of the SEBI (Listing Obligations and Disclosure Requirements) Regulati...more...

  • Alivus Life Sciences Q3 net profit up 9.71% at Rs 150.26 cr 22 Jan 2026 | 15:20 | Dion Global

    The company reported standalone net profit of Rs 150.26 crore for the quarter ended December 31 2025 as compared to Rs 136.96 crore in the same perio...more...

  • Alivus Life Sciences - Investor Presentation 22 Jan 2026 | 14:31 | Dion Global

    Alivus Life Sciences Limited has informed the Exchange about Investor Presentationmore...

DOW Jones45473.550.16%
Nasdaq21794.160.43%
S&P 5006496.040.22%
Nikkei 22543643.811.45%
Hang Seng25633.910.85%
Shanghai Composite3826.840.38%
Sensex74000.14-1.69%
NSE Index22950.55-1.52%
B500DIVL503373.37-0.59%
BSE 1000 9798.66-1.74%
BSE 100LCTMC8499.4-1.62%
BSE Auto 53949.72-2.65%

Commodity

Gold1447830.00%
Silver2342200.00%
Copper1159.15184.24%
Crude Oil887838.44%
Lead196.6546.32%
Mentha Oil1091.12.22%
Nickel1626.8112.13%

Currency

USD/INR 93.88(-0.01 %)
GBP/INR 125.83(0.81 %)
EUR/INR 108.74(0.47 %)
JPY/INR 0.59(0.28 %)
CAD/INR 68.24(-0.21 %)
HKD/INR 11.99(0.04 %)